Samuel Rosner

4PUBLICATIONS
58CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade.

Samuel Rosner, Sydney Connor, Khaled Sanber

|Nov 08, 2023
Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.

Joseph C Murray, Lavanya Sivapalan, Karlijn Hummelink

|Feb 16, 2023
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer.

Samuel Rosner, Joshua E Reuss, Marianna Zahurak

|Dec 18, 2020
Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma.

Samuel Rosner, Yuri Agrawal, Daniel Q Sun

Pageof 1